Kinase Inhibition in Multiple Myeloma: Current Scenario and Clinical Perspectives

Multiple myeloma (MM) is a blood cell neoplasm characterized by excessive production of malignant monoclonal plasma cells (activated B lymphocytes) by the bone marrow, which end up synthesizing antibodies or antibody fragments, called M proteins, in excess. The accumulation of this production, both...

Descripción completa

Detalles Bibliográficos
Autores principales: Barreto, Igor Valentim, Machado, Caio Bezerra, Almeida, Davi Benevides, Pessoa, Flávia Melo Cunha de Pinho, Gadelha, Renan Brito, Pantoja, Laudreísa da Costa, Oliveira, Deivide de Sousa, Ribeiro, Rodrigo Monteiro, Lopes, Germison Silva, de Moraes Filho, Manoel Odorico, de Moraes, Maria Elisabete Amaral, Khayat, André Salim, de Oliveira, Edivaldo Herculano Correa, Moreira-Nunes, Caroline Aquino
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9506264/
https://www.ncbi.nlm.nih.gov/pubmed/36145532
http://dx.doi.org/10.3390/pharmaceutics14091784

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9506264/
https://www.ncbi.nlm.nih.gov/pubmed/36145532
http://dx.doi.org/10.3390/pharmaceutics14091784

Ejemplares similares